KIORA PHARMACEUTICALS INC Income Statement
KPRX|8 years of annual SEC 10-K data (FY2016-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 8 fiscal years. All figures from audited SEC 10-K filings.
KIORA PHARMACEUTICALS INC reported $16M in revenue and $4M in net income for FY2025. Revenue has grown at a 48.7% compound annual rate over the past 8 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.0M | $0 | $12.1K | $2.7M | $1.7M | $407.5K | $669.3K | $0 |
| SG&A Expense | $5.5M | $4.7M | $4.7M | $4.4M | $4.4M | $4.6M | $5.6M | $4.0M |
| R&D Expense | $7.8M | $4.0M | $3.6M | $5.4M | $8.1M | $10.3M | $8.4M | $2.7M |
| Operating Income | $4.5M | -$12.6M | -$8.2M | - | - | -$10.8M | - | - |
| Interest Expense | - | - | $4.2K | $325 | $1.0K | $1.2K | $275 | $1.9M |
| Income Tax | $2.1M | $90.3K | $12.1K | $95.4K | $86.0K | -$1.3M | $0 | - |
| Net Income | $3.6M | -$12.5M | -$8.1M | -$7.1M | -$10.8M | -$13.2M | -$13.3M | -$8.4M |
| EPS (Basic) | $0.93 | -$24.25 | -$1.77 | - | - | - | - | - |
| EPS (Diluted) | $0.87 | -$24.25 | -$1.77 | -$2.23 | -$4.57 | -$0.93 | - | -$2.70 |
| Shares Outstanding | 26.7M | 856.2K | 5.6M | 4.1M | 3.0M | 17.3M | 10.1M | 7.7M |
| Operating Margin | 28.1% | - | -68104.8% | - | - | -2661.2% | - | - |
| Profit Margin | 22.4% | - | -67102.9% | -264.2% | -654.2% | -3243.5% | -1993.8% | - |